Rituximab in the treatment of Sjögren's syndrome: Is It the Right or Wrong Drug?

Hendrika Bootsma*, Frans G. M. Kroese, Arjan Vissink

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)1346-1349
Number of pages4
JournalArthritis & Rheumatology
Volume69
Issue number7
DOIs
Publication statusPublished - Jul-2017

Keywords

  • CONTROLLED-TRIAL
  • DISEASE-ACTIVITY
  • EFFICACY
  • SAFETY
  • INDEX
  • CONSENSUS

Cite this